METHODS FOR TREATING VITREOUS AND RETINAL HEMORRHAGE USING RECOMBINANT PROUROKINASE IN PATIENTS WITH EYEGROUND DISEASE CONCURRENT WITH DIABETIC RETINOPATHY, HYPERTENSIVE RETINOPATHY IN TYPE 2 DIABETES MELLITUS

DOI: https://doi.org/10.29296/25877305-2019-02-15
Download full text PDF
Issue: 
2
Year: 
2019

Professor L. Moshetova(1), MD, Academician of the Russian Academy of Sciences; Professor Yu. Slonimsky(1), MD; I. Vorobeva(1), Candidate of Medical Sciences; A. Dgebuadze(1); O. Agafonova(2), Candidate of Biological Sciences, A. Belogurov2, Candidate of Biological Sciences; E. Delver2, Candidate of Biological Sciences 1-Russian Medical Academy of Continuing Professional Education, Moscow 2-National Medical Research Center of Cardiology, Moscow

Today, recombinant prourokinase is an indispensable Russian enzyme preparation in ophthalmology. Gemase, the active ingredient of which is a human recombinant prourokinase, is capable of quickly eliminating massive hemorrhages into the vitreous body, retina and anterior chamber of the eye. The drug is widely used in hemorrhagic forms of diabetic retinopathy, hypertensive retinopathy, and age-related macular degeneration with a hemorrhagic component. It is effective in treating eye injuries, postoperative fibrinoid syndromes, thrombosis of the central retinal vein and its branches, occlusions of the central retinal artery and its branches.
Keywords: 
endocrinology
ophthalmology
diabetes mellitus
diabetic retinopathy
fibrinolytic
fibrinolytic therapy
Gemase
vitreous body
central retinal thickness

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Bojko E.V., Danilichev V.F., Sazhin T.G. i dr. Vlijanie sposobov vvedenija Gemazy na effektivnost' lechenija gemoftal'ma pri diabeticheskoj retinopatii // Oftal'mologicheskie vedomosti. – 2008; 1 (2): 42–7 [Boiko E.V., Danilichev V.F., Sazhin T.G. et al. The influence of the methods of administration of Gemase on the effectiveness of hemophthalmiatreatment in diabetic retinopathy // Ophthalmological statements. – 2008; 1 (2): 42–7 (in Russ.)].
  2. Balashevich L.I., Izmajlov A.S. (red.). Diabeticheskaja oftal'mopatija / SPb: Chelovek, 2012; 336 s. [Balashevich L.I., Izmaylov A.S. (Ed.) Diabetic ophthalmopathy / SPb: Chelovek, 2012; 336 p. (in Russ.)].
  3. Neroev V.V., Lysenko V.S. Lechenie gemorragicheskogo sindroma pri sosudistyh zabolevanijah setchatki: posobie dlja vrachej / M.: 2004; 8 s. [Neroev V.V., Lysenko V.S. Treatment of hemorrhagic syndrome in vascular diseases of the retina: a guide for doctors / M.: 2004; 8 p. (in Russ.)].
  4. Tahchidi H.P., Shkvorchenko D.O., Levina L.V. i dr. Ispol'zovanie preparata Gemaza v vitreoretinal'noj hirurgii proliferativnoj diabeticheskoj retinopatii // Oftal'mohirurgija. – 2007; 3: 28–34 [Takhchidi Kh.P., Shkvorchenko D.O., Levina L.V. et al. The use of the drug hemaza in vitreoretinal surgery of proliferative diabetic retinopathy // Ophthalmic Surgery. – 2007; 3: 28–34 (in Russ.)].
  5. Vorob'eva I.V., Merkushenkova D.A, Parfenova E.V. i dr. Analiz vlijanija fibrinoliticheskoj terapii gemorragicheskih form diabeticheskoj retinopatii na angiogennyj potentsial glaza // Vestn. oftal'mol. – 2014; 130 (1): 31–6 [Vorobieva I.V., Merkushenkova D.A., Parfenova E.V. et al. Analysis of the effect of fibrinolytic therapy of hemorrhagic forms of diabetic retinopathy on the angiogenic potential of the eye // Bulletin of Ophthalmology. – 2014; 130 (1): 31–6 (in Russ.)].
  6. Nesterov A.P., Balashova L.M., Bibilashvili R.Sh. i dr. Lechenie gemoftal'ma pri diabeticheskoj retinopatii s primeneniem rasshirennoj perifericheskoj transskleral'noj kriopeksii setchatki v sochetanii s in'ektsionnym vvedeniem rekombinantnoj prourokinazy (Gemazy). Tezisy doklada. I Mezhdunarodnaja nauchno-prakticheskaja konferentsija «Proliferativnyj sindrom v oftal'mologii», 2000; 54. [Nesterov A.P., Balashov L.M., Bibilashvili R.Sh. et al. Treatment of hemophthalmus in diabetic retinopathy with the use of extended peripheral transscleral cryopexy in combination with the injection of recombinant prourokinase (Hemase). Abstracts of the report. I International Scientific and Practical Conference «Proliferative Syndrome in Ophthalmology», 2000; 54 (in Russ.)].
  7. Normatova N.M. Rezul'taty ispol'zovanija preparata Gemaza pri lechenii gemoftal'ma u bol'nyh s diabeticheskoj retinopatiej // Saharnyj diabet. – 2010; 2; 97–9 [Normatova N.M. Results of Gemaza therapy of hemophthalmia in patients with diabetic retinopathy // Sakharnyy diabet. – 2010; 2: 97–9 (in Russ.)].
  8. Volkov V.V., Danilov A.B., Rapis E.G. Gemoftal'm / L.: Meditsina, 1990; 62 c. [Volkov V.V., Danilov A.B., Rapis E.G. Hemophthalmus / L.: Meditsina,1990; 62 p. (in Russ.)].
  9. Danilichev V.F. Oftal'mologija. Enzimoterapija i ekstrakorporal'naja gemokorrektsija. Rukovodstvo dlja vrachej / SPb: Gumanistika, 2002; 312 c. [Danilichev V.F. Ophthalmology. Enzymotherapy and extracorporal hemocorrection. A guide for doctors / SPb: Gumanistika, 2002; 312 p. (in Russ.)].